Jennifer Ann Nelson's most recent trade in Omega Therapeutics Inc was a trade of 110,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Nov. 22, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Omega Therapeutics Inc | Jennifer Ann Nelson | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Nov 2024 | 110,000 | 110,000 | - | - | Stock Option (Right to Buy) |